Morgan Dempsey Capital Management LLC Invests $106,000 in Kewaunee Scientific Co. (NASDAQ:KEQU)

Morgan Dempsey Capital Management LLC purchased a new position in Kewaunee Scientific Co. (NASDAQ:KEQU) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,720 shares of the technology company’s stock, valued at approximately $106,000. Morgan Dempsey Capital Management LLC owned approximately 0.06% of Kewaunee Scientific as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Geode Capital Management LLC grew its stake in Kewaunee Scientific by 8.9% in the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after purchasing an additional 1,941 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after purchasing an additional 900 shares in the last quarter. Janney Montgomery Scott LLC acquired a new position in Kewaunee Scientific in the fourth quarter worth about $338,000. Barclays PLC acquired a new position in Kewaunee Scientific in the third quarter worth about $121,000. Finally, State Street Corp acquired a new position in Kewaunee Scientific in the third quarter worth about $266,000. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Kewaunee Scientific Stock Performance

Shares of KEQU stock opened at $54.36 on Friday. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45. The business has a 50 day moving average of $61.10 and a two-hundred day moving average of $47.99. Kewaunee Scientific Co. has a 52 week low of $27.00 and a 52 week high of $71.33. The company has a market cap of $156.12 million, a P/E ratio of 8.61 and a beta of 0.71.

Kewaunee Scientific (NASDAQ:KEQU) last issued its earnings results on Wednesday, December 11th. The technology company reported $1.41 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Analyst Ratings Changes

Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Insider Buying and Selling at Kewaunee Scientific

In other news, VP Elizabeth D. Phillips sold 1,850 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the transaction, the vice president now directly owns 13,591 shares in the company, valued at approximately $736,224.47. The trade was a 11.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Douglas J. Batdorff sold 3,470 shares of the business’s stock in a transaction that occurred on Monday, December 30th. The stock was sold at an average price of $65.50, for a total value of $227,285.00. Following the transaction, the vice president now owns 5,000 shares of the company’s stock, valued at approximately $327,500. This represents a 40.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,994 shares of company stock worth $729,430 over the last ninety days. Company insiders own 14.20% of the company’s stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.